JESSICA JONES: Open Payments
NPI 1528309986 · HATTIESBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$951 in 69 payments from 10 companies in 2025. Trend: 2023 $1,315 · 2024 $1,042 · 2025 $951
Food & beverage: $951
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 49 | $573 |
| Janssen Biotech, Inc. | 6 | $128 |
| Regeneron Healthcare Solutions, Inc. | 2 | $55 |
| Madrigal Pharmaceuticals | 3 | $48 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $42 |
| Intercept Pharmaceuticals, Inc. | 2 | $35 |
| Lilly USA, LLC | 2 | $31 |
| Ardelyx, Inc. | 1 | $17 |
| Ipsen Biopharmaceuticals, Inc | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $6 |
Products named: RINVOQ, TREMFYA, CREON, SKYRIZI, DUPIXENT, REZDIFFRA, LINZESS, ENTYVIO.
Industry payments across MS — which companies pay providers there.
